Tagged with M&A

Artificial Intelligence Digital health deal values in biopharma jumped to USD 6.4 billion in 2019, largely thanks to software company Dassault Systemes Americas Corp.’s USD 5.9 billion acquisition of health tech company Medidata Solutions, according to analysis by S&P Global Market Intelligence. “Traditional investors in the digital health startup space have generally…

Opinion Michael Jewell, partner and head of healthcare & life sciences at Cavendish Corporate Finance looks back at the key trends across pharma industry funding in 2019 and gives his perspective on how 2020 will look.   As we approach the end of 2019, it’s a good time to look back…

Generics Despite being recently divested from multinational pharma giant Sanofi, Czech firm Zentiva is becoming one of the fastest-growing generics manufacturing companies in Europe, with a swathe of recent international acquisitions strengthening its position.   Zentiva, a Czech Republic-based generics manufacturer, is on a mission to expand its reach after being…

Opinion Anthony Harrington of global investment banking and asset management firm Alantra outlines why healthcare and consulting communications companies are increasingly attractive targets for private equity.   The supply of PE money chasing fewer and fewer assets is only going to increase the attraction of healthcare communications and consulting firms to…

Sweden AddLife is a Swedish company that acquires and streamlines profitable market-leading niche companies in the field of life science. CEO Kristina Willgård examines the company’s international expansion strategy and the goal of doubling in size in five years, highlights her personal commitment to sustainability, and the challenges facing the laboratory…

Sweden Changing demographics and revolutionary technological advancements are altering the structure of the medtech industry paving the way for Arjo, a global Swedish supplier of medical devices and solutions, to rise up to the challenge. CEO Joacim Lindoff discusses the journey after Arjo’s split from Getinge in 2017, the company’s revived…

Sweden Karo Pharma is a Swedish specialty pharma company that develops and markets products to pharmacies and healthcare providers. CEO Christoffer Lorenzen discusses the company’s growth strategy through acquisitions of trusted well-positioned brands, the challenge of incorporating two similar-sized companies, and his high ambitions for the future of Karo Pharma.  …

Opinion David H. Crean, managing director for Objective Capital Partners, highlights the latest trends in mergers and acquisition (M&A) activities involving companies with artificial intelligence/machine learning platforms and technologies and their application to healthcare companies.   Artificial Intelligence Advances in technologies, an incorporation of entrants from outside the industry and changing consumer…

Spain The global acquisition of GSK’s thrombosis portfolio and subsequent purchase of AstraZeneca’s anaesthesia business have been critical milestones for the maverick South African pharmaceutical outfit Aspen, enabling the company to establish a consolidated presence across Europe, including the opening of the firm’s first-ever Spanish affiliate only two and a half…

Germany Bayer’s latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as the company increasingly looks toward cell and gene therapies to bolster its development pipeline and create transformative biotechnological solutions.   German pharmaceutical company Bayer AG is setting its sights on…

Thailand Peter Streibl, general manager of Takeda Thailand, highlights the importance of emerging markets for Takeda globally, as well as the 50–year long commitment of Takeda to Thailand and Thai patients. Streibl further discusses how the Takeda Thailand team has worked to bring crucial innovative products and solutions in various therapeutic…

Thailand Thanakorn and Lakana Ounpiyodom of AeroCare highlight their unique positioning in the inhaler niche and how they have grown both their portfolio and facilities through strategic M&A. They share their strong interest in delivering the most innovative products in the field to Thai patients, and their wish to expand across…